These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21835703)

  • 1. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.
    Ridderberg W; Bendstrup KE; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    J Cyst Fibros; 2011 Dec; 10(6):466-9. PubMed ID: 21835703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
    Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
    J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.
    Pereira RH; Carvalho-Assef AP; Albano RM; Folescu TW; Jones MC; Leão RS; Marques EA
    J Clin Microbiol; 2011 Oct; 49(10):3649-51. PubMed ID: 21849686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 9. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
    Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study.
    Rønne Hansen C; Pressler T; Høiby N; Gormsen M
    J Cyst Fibros; 2006 Dec; 5(4):245-51. PubMed ID: 16777495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans.
    Reddy AK; Garg P; Shah V; Gopinathan U
    Cornea; 2009 Dec; 28(10):1100-3. PubMed ID: 19730091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.
    Shie SS; Huang CT; Leu HS
    J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species.
    Turton JF; Mustafa N; Shah J; Hampton CV; Pike R; Kenna DT
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):408-11. PubMed ID: 21497041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137.
    Amoureux L; Sauge J; Sarret B; Lhoumeau M; Bajard A; Tetu J; Bador J; Neuwirth C;
    J Cyst Fibros; 2019 Nov; 18(6):804-807. PubMed ID: 31104975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014.
    Amoureux L; Bador J; Neuwirth C
    Emerg Infect Dis; 2019 Nov; 25(11):2158-2159. PubMed ID: 31625846
    [No Abstract]   [Full Text] [Related]  

  • 18. A Case of Phage Therapy against Pandrug-Resistant
    Lebeaux D; Merabishvili M; Caudron E; Lannoy D; Van Simaey L; Duyvejonck H; Guillemain R; Thumerelle C; Podglajen I; Compain F; Kassis N; Mainardi JL; Wittmann J; Rohde C; Pirnay JP; Dufour N; Vermeulen S; Gansemans Y; Van Nieuwerburgh F; Vaneechoutte M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India.
    Kumar A; Ray P; Kanwar M; Sethi S; Narang A
    J Hosp Infect; 2006 Feb; 62(2):248-50. PubMed ID: 16289456
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.